Lyndra to develop ultra-long-acting opioid use disorder therapy
Lyndra Therapeutics (Watertown, Mass.) announced that it is developing an ultra-long-acting oral treatment for opioid use disorder.
On average, about 130 Americans die every day from an opioid overdose, according to the Centers for Disease Control and Prevention. Lyndra Therapeutics received a grant from the National Institutes of Health to help find new treatment strategies and formulations of existing medications to address the opioid epidemic.
The grant covers the development of a once-a-week oral dosage of buprenorphine, which is a medication-assisted treatment that has shown to have improved outcomes for patients wi...
Source: Mass Device - April 9, 2019 Category: Medical Devices Authors: Danielle Kirsh Tags: Pain Management lyndra Source Type: news
Histogenics to merge with Ocugen
Histogenics (NSDQ:HSGX) said yesterday that it inked a definitive merger agreement with Ocugen through which both companies will combine into a single publicly-traded, clinical-stage biopharmaceutical company.
The combined entity will operate under the Ocugen name, the companies said. As part of the deal, Ocugen’s shareholders will become the majority owners of Histogenics outstanding common stock upon the closure of the merger.
Read the whole story on our sister site, Drug Delivery Business News (Source: Mass Device)
Source: Mass Device - April 9, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Mergers & Acquisitions Wall Street Beat Histogenics ocugen Source Type: news
J & J ’ s Ethicon touts economic study of magnetic Torax GERD device
This study suggests that perception may be short-sighted in that insurance plans can provide better care for their GERD patients at a similar cost to laparoscopic Nissen fundoplication when you factor in the greater reductions in medical costs after the procedure.”
“This study demonstrated that the Linx System was cost effective and should be more widely covered by insurers,” added Ethicon endomechanical president Tom O’Brien. “Ethicon will continue to help support studies that enable clinicians, patients, insurers and health systems to make the best possible decisions about which treatments w...
Source: Mass Device - April 9, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Weight loss Ethicon johnsonandjohnson Torax Medical Inc. Source Type: news
Novartis completes spinout of Alcon eye biz
Novartis (NYSE:NVS) closed the spinout of its Alcon vision care business, setting the stage for its shares to begin trading today in Switzerland and New York.
The spinout, announced last June, saw each Novartis shareholder receive a single ALC share for every five NVS shares as of the close of business April 1, Novartis said last month.
“For more than 70 years, Alcon has been dedicated to helping people see brilliantly and now, as an independent company, we are pursuing even more opportunities to further that mission,” CEO David Endicott said in prepared remarks. “We are poised to achieve sustainable gro...
Source: Mass Device - April 9, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Featured Mergers & Acquisitions Vision Wall Street Beat Alcon Novartis Source Type: news
Silk Road Medical clears $109m in IPO
Silk Road Medical (NSDQ:SILK) said yesterday that it cleared just more than $109 million in its initial public offering, including a fully subscribed underwriters option.
The $20-per-share flotation grossed $120 million, Sunnyvale, Calif.-based Silk Road said. The company is developing a neuroprotection and stent system called Enroute as an aid to transcarotid artery revascularization procedures. Silk Road’s estimated net proceeds of $109.1 million are earmarked for sales force expansion, new clinical trials, increasing its international footprint and potentially for acquisitions.
president & CEO Erica Rogers t...
Source: Mass Device - April 9, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Featured Funding Roundup Neurological Wall Street Beat Silk Road Medical Inc. Source Type: news
Japan increases medical device registration fees
By Stewart Eisenhart, Emergo Group
Japan’s Pharmaceutical and Medical Devices Agency (PMDA) has increased registration, inspection and related regulatory fees for medical device market applicants.
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees. (Source: Mass Device)
Source: Mass Device - April 9, 2019 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog Emergo Group Source Type: news
Mick Jagger is giving TAVR a boost: Here ’ s how
Mick Jagger during a concert in Warsaw, Poland in 2018 [Image by Jerzy Bednarski – Own work, CC BY-SA 4.0]A successful transcatheter aortic valve replacement (TAVR) recovery for rock icon Mick Jagger could be good news for companies such as Medtronic (NYSE:MDT) and Edwards Lifesciences (NYSE:EW) that make devices for the procedure, according to analysts following the medical device industry.
The Rolling Stone frontman tweeted Friday that he was feeling better and on the mend after undergoing the procedure at a New York hospital.
“We think Mick Jagger’s TAVR procedure will likely raise awareness of aortic sten...
Source: Mass Device - April 8, 2019 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News Cardiovascular Featured News Well Edwards Lifesciences Medtronic tavr Source Type: news
AirXpanders touts study results
AirXpanders (ASX:AXP) said that a retrospective clinical study has concluded that the use of its AeroForm tissue expanders may be associated with reduced infection rates, less medical treatment and lower costs for patients and health systems.
The Palo Alto-based company makes the AeroForm tissue expander for post-mastectomy breast reconstruction. The device is designed to expand and stretch the skin and underlying muscle prior to a permanent breast implant using small amounts of CO2 up to three times a day.
Get the full story on our sister site, Medical Design & Outsourcing. (Source: Mass Device)
Source: Mass Device - April 8, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Clinical Trials Featured Hospital Care Implants News Well Oncology Surgical Women's Health AirXpanders Johns Hopkins University Source Type: news
Medtronic touts economic data for HeartWare HVAD
Medtronic (NYSE:MDT) today touted more data on the HeartWare left-ventricular assist device it acquired in 2016, saying economic analyses of prior trials showed its cost effectiveness.
The Fridley, Minn.-based medical device giant said one analysis, of data from the Lateral thoracotomy study showed that patients implanted with its HVAD pump incurred lower hospitalization and medical supply costs than patients implanted via sternotomy. The average total cost per thoracotomy patient was $204,107, compared with $260,492 for traditional median sternotomy. Lateral also showed an 87% survival rate at two years and a 30% in leng...
Source: Mass Device - April 8, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Cardiac Assist Devices Clinical Trials Featured Medtronic Source Type: news
Irish medtech startup wins $3M in grants
The BioHealx technology is designed to treat anal fistula. (Image from Signum Surgical)
Galway, Ireland-based startup Signum Surgical said today that it has landed more than $3 million in grants to help fund its efforts to gain U.S. and European regulatory clearance of a device intended to treat a condition that can cause fecal incontinence.
The grants include $2.04 million from the European Union Horizon 2020 SME Instrument and $1.15 million from Ireland’s Disruptive Technologies Innovation Fund (DTIF). Part of the money will help Signum Surgical launch of a 12-month clinical study of its BioHealx device, which is desig...
Source: Mass Device - April 8, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Featured Funding Roundup Implants News Well signumsurgical Source Type: news
Final defendant sentenced in insider trading case
Federal prosecutors have wrapped up an insider trading case based on alleged tips from a Bank of America consultant on pending corporate transactions, including Abbott‘s (NYSE:ABT) $25 billion acquisition of St. Jude Medical.
Rodolfo Sablon, 39, of Miami, Fla., was sentenced Friday to six months in prison for his role in the insider trading scheme based on tips from Bank of America technical consultant Daniel Rivas. U.S. District Judge Alison Nathan also sentenced Sablon to two years of supervised release, including six months in a community confinement center, and ordered him to pay $923,566 in forfeiture and a $5,000 ...
Source: Mass Device - April 8, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Featured Legal News Mergers & Acquisitions News Well Wall Street Beat Abbott st.judemedical Source Type: news
Medtronic, BCBS Minnesota ink value-based diabetes deal
Medtronic (NYSE:MDT) said today that it inked a deal with Blue Cross & Blue Shield of Minnesota on an outcomes-based program for diabetes patients.
The plan gives BCBS Minnesota members access to Medtronic’s Guardian Connect continuous glucose monitor via a pharmacy benefit, with payments pegged to how long patients spend in a targeted blood glucose range. The deal also includes access to the company’s Inner Circle patient engagement program, which aims to use gamification to improve outcomes, for people using Guardian Connect and Medtronic’s MiniMed 670G pump.
Get the full story at our sister site, Drug Deliver...
Source: Mass Device - April 8, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Diabetes Featured Wall Street Beat Blue Cross Blue Shield Medtronic Source Type: news
Report: J & J plans €100m expansion in Ireland, to add 100 jobs
Johnson & Johnson (NYSE:JNJ) is reportedly planning to expand its vision business in Ireland with a €100 million project that’s slated to add 100 jobs to the local economy.
The plant in Limerick is expected to bring 100 permanent jobs on top of 200 temporary construction jobs, Silicon Republic reported.
“We believe that the new manufacturing roles being introduced in Limerick in 2019 will be foundational in helping us bring new, innovative contact lens products to our patients and customers around the world at an industry-leading pace,” J&J Vision Care plant leader John Lynch said.
J&J Visio...
Source: Mass Device - April 8, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Business/Financial News Vision johnsonandjohnson Source Type: news
Medtronic touts new targeted drug delivery study results
Targeted drug delivery and conventional medical management have shown to have a reduction in healthcare use and costs for cancer patients in comparison to conventional medical management alone, according to a new study from Medtronic.
The study found that there were significant cost savings to payers and fewer inpatient visits with shorter inpatient stays. It also showed that there were fewer emergency department visits for people who used targeted drug delivery (TDD) and conventional medical management (CMM).
Medtronic suggests that TDD therapy had a significant average overall cost savings of $63,498 with fewer opioid pr...
Source: Mass Device - April 8, 2019 Category: Medical Devices Authors: Danielle Kirsh Tags: Pain Management Medtronic Source Type: news
Varian leads $54m Series C for HistoSonics
HistoSonics said today that it closed a $54 million Series C round led by Varian Medical (NYSE:VAR) that included a contribution from Johnson & Johnson (NYSE:JNJ).
The Ann Arbor, Mich.-based company, which is developing an image-guided, robotically assisted platform using non-invasive and non-thermal technologies, said Lumira Ventures, Venture Investors, the State of Wisconsin Investment Board and existing backers also participated – including robot-assisted surgery pioneer Dr. Fred Moll.
HistoSonics said it plans to use the proceeds to complete “key regulatory and commercial milestones” and expand its d...
Source: Mass Device - April 8, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Featured Funding Roundup Robotics Wall Street Beat HistoSonics Inc. johnsonandjohnson Varian Medical Systems Source Type: news
